AlphaStocks
6.9
Consider Buy

Acadia Pharmaceuticals Inc (ACAD)

As of Sep 20, 2026, Acadia Pharmaceuticals Inc (ACAD) scores 6.9/10 on AlphaStocks' five-model composite, #15 of 168 Health Care stocks.

Health Care / Pharmaceuticals

S&P SmallCap 600

$27.27

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 3 of 5 models — moderate confidence

Data as of Sep 20, 2026

#15out of 168 in Health Care

Is ACADIA PHARMACEUTICALS INC a Good Investment in 2026?

ACADIA PHARMACEUTICALS INC (ACAD) scores 6.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates ACADIA PHARMACEUTICALS INC as Attractive (5/9). The Graham model is the least favorable, rating it Neutral. ACADIA PHARMACEUTICALS INC ranks #15 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E11.8ROE12.9Market Cap5B

Valuation

Trades at 12x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

14% below fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is ACADIA PHARMACEUTICALS INC (ACAD) a good investment?
As of Sep 20, 2026, Acadia Pharmaceuticals Inc (ACAD) scores 6.9/10 on AlphaStocks' five-model composite, #15 of 168 Health Care stocks. That is a middle-of-the-pack score with no strong signal either way. Trades at 12x earnings — near sector median of 30x.
What is ACADIA PHARMACEUTICALS INC's Piotroski F-Score?
ACADIA PHARMACEUTICALS INC's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ACAD overvalued or undervalued?
A precise fair value estimate is not available for ACAD. Trades at 12x earnings — near sector median of 30x.
How does ACAD compare to other Health Care stocks?
ACADIA PHARMACEUTICALS INC ranks #15 out of 168 stocks in the Health Care sector, placing it in the top 9% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about ACAD?
AlphaStocks evaluates ACAD using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral. These models are combined into a single composite score of 6.9/10.

Similar Stocks

AMPHLLYAMRX

Compare ACAD with

ACAD vs AMPHACAD vs LLYACAD vs AMRX

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer